Introduction
On 24 April 2009, the United States (US) Centers for Disease Control and Prevention (CDC) reported eight confirmed cases of a novel strain of influenza A(H1N1) in Texas and California, and Mexico confirmed the same virus in 16 samples [1] [2] [3] [4] [5] . That same day, the Ministry of Health of Chile alerted all regions of the country, so they could strengthen their surveillance of respiratory viruses and maximise infection control measures.
On 17 May, the first two cases of the 2009 pandemic influenza A(H1N1) were confirmed in the Metropolitan region of Santiago, in a person returning from Punta Cana (Dominican Republic) and another with no history of travel outside Chile. The first case in Puerto Montt (Region of Los Lagos) was laboratory-confirmed on 26 May. One week later, Chile reported 500 confirmed cases throughout the country, among those seven cases with severe acute respiratory infection (SARI) and two fatalities. Because six of the SARI cases and the two deaths occurred in the region of Los Lagos, the Ministry of Health formed a field team on 1 June to investigate the outbreak in Puerto Montt. This team conducted a retrospective study from 1 April to 31 May, in order to establish the date of the beginning of the outbreak, and a follow study until 27 June to establish its real magnitude, and to describe its transmission and clinical severity.
The Los Lagos region, in the south of the country, has 825,000 inhabitants and is one of the 15 regions in Chile. The capital Puerto Montt with 230,855 inhabitants has the second most important airport in the country in terms of air traffic. This city receives many foreign travellers for business or tourism. The climate is cold, with temperatures fluctuating between 0 ºC and 8 ºC during the period of this study (1 April to 27 June).
The surveillance of influenza-like illnesses (ILI) in the region is carried out through sentinel units in ambulatory care centres and hospitals.
Until 6 October, Chile reported 12,254 confirmed cases of pandemic influenza, of which 1,585 (9.4 per 100,000 inhabitants) were cases with SARI including 134 fatalities (0.8 per 100,000 inhabitants); only one fatality was a pregnant woman. Los Lagos had the third highest rate of severe cases of the country (30.8 per 100,000 inhabitants) and the fourth highest mortality rate (1.33 per 100,000 inhabitants).
It is noteworthy that Chile indicates treatment with oseltamivir with a doctor's prescription for anybody older than five years of age whose symptoms comply with the case definition.
Methods
In order to establish the date of the beginning of the outbreak, its magnitude, transmission and clinical severity, we carried out a retrospective study using data on emergency room visits, from 1 April to 31 May 2008 and for the same period in 2009 at the two main health facilities in Puerto Montt. The following diagnoses were included: respiratory viral disease, influenza, severe acute respiratory infection, pneumonia, pneumonitis, obstructive bronchial syndrome, bronchitis, rhinopharyngitis, common cold and febrile syndrome. In addition, for the same period, a review of viral surveillance was conducted in the local laboratory registers.
From 1 June, case follow-up was implemented: In all healthcare facilities, in the public and private sector, people who fulfilled the following definition of a suspected case were notified: "any person presenting a fever of 38.5 °C or higher accompanied by coughing and any of the following symptoms: headache, myalgia, arthralgias, and/or sore throat". In order to identify suspected cases with SARI, the presence of dyspnoea, tachypnoea, cyanosis, or hypoxaemia was added to the previous case definition, and dehydration or food rejection was added for cases involving infants.
In addition, household visits were carried out to conduct in-depth interviews with laboratory-confirmed cases and their contacts at home, in order to determine the secondary attack rate. A symptomatic contact of the index case was defined as anyone developing ILI within 14 days following the date of onset of symptoms of the confirmed case. Interviews were also conducted with family members and with healthcare personnel who personally provided patient care, to establish the date of symptoms onset, the date of first medical attention and hospitalisation, risk factors and clinical evolution of severe and fatal cases. Clinical files of hospitalised patients and fatal cases in the two facilities were also reviewed.
All respiratory samples (nasopharyngeal aspiration) were analysed by direct and indirect immunofluorescence and by the real-time RT-PCR distributed by the US CDC to all national influenza centres.
The reproduction number R was estimated using the Wallinga and Lipsitch linearisation method based on the intrinsic growth rate r of the epidemic curve in its initial phase, which was assumed exponentially by visual inspection of the epidemic curve. The assumption was that its initial phase corresponded to the first 20 days of consecutive transmission (between 15 May and 3 June) and that the intrinsic growth rate corresponded to the beta (slope) of the curve. The merit adjustment was estimated using the exponential regression coefficient for ascertainment. As the average latent period, 1.0 days was chosen and for infectiousness, 1.5 days [6] [7] [8] [9] .
Results

Identification and general characteristics of the cases
A 23% increase in pneumonias was observed in 2009 from 1 April onwards, compared with 2008; however, this increase was not significant (p=0.159). The first case of pandemic influenza was confirmed on 26 May. However, the retrospective study showed that the first case had occurred on 28 April. Figure 1 ). For the cases observed before 26 May, the average period between the date of onset of symptoms and the first consultation was three days. After that date, the average period fell to 0.91 days.
The most affected age groups were the 5-19-year-olds (12.6 per 100,000 inhabitants) and the 20-29-yearolds (11.9 per 100,000 inhabitants). No significant differences were observed by sex. The main clinical characteristics were fever (96.2%), cough (78.0%), myalgia (69.8%), sore throat (57.4%), vomiting (35.0%), diarrhoea (28.2%) and conjunctivitis (21.4%).
Laboratory surveillance
Of a total of 473 respiratory samples (nasopharyngeal aspiration) processed by the Chilean Institute of Public Health (Instituto de Salud Pública), 297 (62.79%) were positive for pandemic influenza A(H1N1), five (1.06%) were positive for seasonal influenza (H1 and H3), and 171 (36.15%) were negative for both. The highest percentage of pandemic influenza infections was found in the age groups between five and 29 years ( Table 1) .
The viral surveillance (Figures 2: weeks 1-21 and Figure  3 : weeks 1-25) showed an increase in the circulation of pandemic influenza and untyped influenza over week 21, especially in children under five (from 18.25% to 37.05%). Also observed was an increase in the circulation of respiratory syncytial virus (RSV, 32%), affecting in particular children under the age of one year.
Geographical spread
The first cases were detected in week 17 in the city of Puerto Montt (where the airport is located), spreading at a rate between one and two new communes per week during the first three weeks (from one commune in week 17 to six communes in week 19) and between six and seven new communes per week during the following three weeks (from six communes in week 20 to 26 in week 23). Six weeks after the first case detection (week 23), 26 of the 30 communes had been affected. Those with the highest rates per 100,000 inhabitants were Hualaihué (27.3), Osorno (7.8), Puyehue (6.2), Río Negro (4.5) and Llanquihue (4.6), while the overall rate for the region was 1.2. The communes that did not present any cases up to week 23 were Futaleufú, Chaitén, Queilén, and Quinchao (the latter two on the island of Chiloé), see Figure 4 .
Analysis of transmission Initial estimate of transmission reproduction number R)
The exploratory analysis for a complete series of 20 days (15 May-3 June) showed an effective reproduction number (R) equal to 1.8 (confidence interval (CI):1.6-2.0); for 15 days (20 May-3 June) the R was 1.9 (CI:1.7-2.2), for 10 days (24 May-3 June) R was 2.0 (CI:1.7-2.3), and for the last five days (30 May-3 June) R fell to 1.6 (CI: 1.5-1.8). Of all 89 symptomatic contacts studied, 35 presented symptoms before the household index case and 54 were classified as secondary cases of the index case, representing a secondary attack rate of 35.0% (54 out of 146).
Transmission among household contacts
With the available information on the 54 secondary cases, the average time between the date of onset of symptoms of the index case and the date of onset of symptoms of the contact (generation interval) was 3.61 days (median: three days, ranging from less than 24 hours to nine days).
Transmission among healthcare workers
Forty-one healthcare personnel were interviewed, 20 presented respiratory symptoms within the four weeks prior to interview (48.7%); and 34 (82.9%) staff members indicated that they had had contact with suspected or confirmed cases in the community. Of the symptomatic healthcare workers, 47.2% had been vaccinated, but only 25% of the asymptomatic healthcare workers. An evaluation of the compliance with treatment guidelines for symptomatic healthcare workers (with oseltamivir) showed that only two cases received treatment with oseltamivir.
Severity analysis
General characteristics
The proportion of cases who developed a SARI and required hospitalisation was 1.3% (190 of all 14,559 cases). The first cases with SARI were hospitalised from the middle of May (week 22) onwards, 20 days after the first case had been detected in the retrospective search, and eight days before the first case in Puerto Montt's (index case) had been detected (see Figure 1) . A gradual increase in hospitalised cases was observed up to 23 June, when the number of cases with SARI rose to twelve on that day alone.
Among the 190 cases of SARI with a confirmed diagnosis, the median age was 27 years (0-85), 47.4% being male (90 of 190). The age group most affected were children under five years (73 per 100,000 inhabitants), followed by those over 60 years of age (22 per 100,000), 40-59 years (20.3 per 100,000), 20-39 years (18 per 100,000), and finally those between five and 19 years of age (17 per 100,000 inhabitants).
As of 27 June 2009, 10 deaths have been reported (a fatality rate of 0.19%) eight male and two female: a sixyear-old boy, seven young adults between 18 and 64 years of age, and two elderly adults aged between 65 and 85.
Co-morbidity in severe cases
Of the 190 cases with confirmed SARI, 71 (37.4%) presented an underlying risk condition or illness.
The interviews with the 57 confirmed cases (37 mild cases and 20 cases with SARI) and the review of the clinical files showed that presenting some underlying evidence of co-morbidity increased the risk of presenting SARI (14.3% in the mild cases versus 57.9% in the cases with SARI (odds ratio (OR)=8.25; CI: 2.22 to 30.60; p=0.0013). The underlying risk factors in the acute cases were pulmonary disease (six), obesity (three), heart disease (three), diabetes (one), alcoholism (one) and smoking (two). Of these cases, three presented two or more underlying conditions. Of the 10 deaths, five showed between one and three risk factors: obesity (two), heart disease (three), hypertension (one), diabetes (one), chronic obstructive pulmonary disease (one), pulmonary fibrosis (one), and heavy smoking (two).
Clinical and laboratory characteristics in severe cases
The main results from the 20 hospitalised cases studied in depth are shown in Table 2 . The characteristics at the beginning of the clinical profile did not differ between the group of people with mild disease and those with severe disease. With respect to chest X-rays performed at the time of admission, seven presented images compatible with pneumonia, 11 presented interstitial infiltrate, and in two cases the X-rays were not available.
Of the severe cases, 11 were admitted with evidence of hypoxia, for which they required oxygen at that time; however, all patients required oxygen at some point during their hospitalisation.
The serum glutamic oxaloacetic and glutamic pyruvic transaminases at the time of admission reached average values of 321 U/L (range: 60-583) and 105 U/L (range: 19-354), respectively. The rest of the laboratory tests performed at the time of admission were found to fall within the reference values.
Discussion
As a result of this study, it was possible to determine that the outbreak of pandemic influenza A(H1N1) in Los Lagos started on 28 April 2009 (week 17), before the confirmation of the first case in the country (17 May, week 20). It probably originated due to the high level of international commercial activity in that region.
By week 23, the virus had spread to 26 of 30 communes in Los Lagos, reaching a total of 14,559 cases. Regarding transmission, the preliminary reproduction number for the initial phase (1.6-2.0) was higher than estimated for the outbreak in Mexico (1.4-1.6) and lower than estimated for the outbreak in Japan (2.0-2.6) [7, 8] .
Household prevalence was higher, at 59.2%, probably due to lifestyle factors related to the low temperatures during the period of investigation; while the secondary attack rate (35.0%) and the generation interval (3.61 days) were similar to the values found in Mexico (31% and 3.9 days, respectively (10) . Although high levels of transmission were found among healthcare personnel (48.7%), no link with hospitalised patients could be established, because 83% of the staff had had contact with suspected or confirmed cases in the community.
The highest rates of SARI were in small children and elderly people, while mild disease was more frequent in school children and young adults.
One of the main limitations of this study was the small number of patients with SARI who were studied in depth. Further analysis will include all cases that occurred in Los Lagos during the winter season, which will give us more information on the clinical presentation and serious risk factors.
